EMILIN1 and breast carcinoma: These findings suggest that CAF plays a crucial role in modulating the TIME through the regulation of TGF-β signaling, and EMILIN1 may serve as a potential prognostic marker and therapeutic target, offering new directions for precision therapy in breast cancer.